ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,000 | -13.0% | 1,148 | +1.2% | 0.01% | -25.0% |
| Q2 2020 | $54,000 | +12.5% | 1,134 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $48,000 | -2.0% | 1,134 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $49,000 | +22.5% | 1,134 | 0.0% | 0.01% | +12.5% |
| Q3 2019 | $40,000 | +33.3% | 1,134 | 0.0% | 0.01% | +33.3% |
| Q2 2019 | $30,000 | -86.2% | 1,134 | -86.1% | 0.01% | -86.7% |
| Q1 2019 | $218,000 | +66.4% | 8,134 | 0.0% | 0.04% | +40.6% |
| Q4 2018 | $131,000 | -43.3% | 8,134 | -26.9% | 0.03% | -25.6% |
| Q3 2018 | $231,000 | +29.1% | 11,134 | -5.5% | 0.04% | +19.4% |
| Q2 2018 | $179,000 | -31.2% | 11,784 | +71.2% | 0.04% | -57.1% |
| Q3 2017 | $260,000 | +28.7% | 6,884 | +10.4% | 0.08% | +9.1% |
| Q1 2017 | $202,000 | – | 6,234 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |